Nuo Therapeutics Inc (NUOTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 2,424 | 2,317 | 2,103 | 1,759 | 3,685 |
| Cost of Goods | 1,359 | 1,272 | 1,088 | 998 | 980 |
| Gross Profit | 1,065 | 1,045 | 1,015 | 761 | 2,705 |
| Operating Expenses | 6,086 | 6,321 | 4,721 | 5,968 | 6,034 |
| Operating Income | -4,662 | -5,003 | -3,619 | -4,208 | -2,349 |
| Interest Expense | 426 | 519 | 244 | 262 | 268 |
| Other Income | 56 | 189 | 34 | 690 | -4,835 |
| Pre-tax Income | -5,032 | -5,334 | -3,830 | -3,780 | -7,451 |
| Income Tax | 5 | 5 | 4 | 5 | 5 |
| Net Income Continuous | -5,037 | -5,339 | -3,834 | -3,785 | -7,456 |
| Net Income | $-5,037 | $-5,339 | $-3,834 | $-3,785 | $-7,456 |
| EPS Basic Total Ops | -0.05 | -0.05 | -0.04 | -0.04 | -0.09 |
| EPS Basic Continuous Ops | -0.05 | -0.05 | -0.03 | -0.04 | -0.09 |
| EPS Diluted Total Ops | -0.05 | N/A | -0.04 | -0.04 | -0.09 |
| EPS Diluted Continuous Ops | -0.05 | N/A | -0.03 | -0.04 | -0.09 |
| EBITDA(a) | $-4,283 | $-4,628 | $-3,247 | $-3,852 | $-2,020 |